Skip to main content

Table 1 Clusterin expression pattern in the primary and recurrent ovarian cancers

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Case (patient's age) Chemo-senitivity primary tumor Persistent/recurrent t. histology FIGO stage
   CLU intensity CLU intensity   
1 (57) responsive ++ + serous IIIc
2 (48) responsive ++ + serous IIIc
3 (48) resistant + ++ serous IV
4 (53) resistant + +++ serous IV
5 (59) resistant + +++ serous IV
6 (52) resistant ++ +++ serous IIIc
7 (51) resistant N ++ serous IV
8 (55) resistant +++ +++ serous IIIC
  1. N denotes negative staining, (+) denote weak staining (++) denote moderate staining, while (+++) denotes strong staining.